XHKG
8161
, Last price
HKD
Name
MediNet Group Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
MediNet Group Limited, an investment holding entity, delivers a wide array of medical and dental services to corporations, insurance companies, and private individuals across Hong Kong and the People's Republic of China. The company manages two MediNet Centres, providing general practitioner consultations, immunization programs, men's health services, and comprehensive health assessments and body check-ups. Its operations also encompass six dental clinics, which offer a full spectrum of oral care, from routine services like scaling, polishing, fillings, and intra-oral X-rays, to advanced treatments such as cosmetic dentistry, orthodontics (including Invisalign), restorative solutions (dentures, veneers, implants), and oral and dental laser implant surgery, catering to both plan members and self-paying clients. Furthermore, MediNet operates a dedicated DNA genetic laboratory. The group also extends its services to include physiotherapy, traditional Chinese medicine practitioners, vaccinations, X-ray and diagnostic laboratory tests, and various specialist medical consultations. Additionally, MediNet utilizes online platforms to facilitate the sale of dental and medical consultation services. Established in 1994, the company is headquartered in Causeway Bay, Hong Kong, and operates as a subsidiary of MediNet International Limited.
Key people
Christine Li
Assistant General Manager
Pui Shan Ngan
Financial Controller
Jie Jiang
Executive Director · since 2015
Mei Shu Chung
Dentist and a Director of Well Being Dental
Siu Kay Wong
Dentist and a Director of Well Being Dental · since 2016
Company Secretary · since 2015
Chi Wai Chan
Executive Chairman of the Board, Compliance Officer, General Manager · since 2015
Po Hon Leung
Non-Executive Independent Director · since 2016
Geoffrey Sek Yiu Lieu
Non-Executive Independent Director · since 2016
Non-Executive Independent Director · since 2016
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||